Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.42 HKD
Change Today +0.01 / 2.47%
Volume 3.8M
8197 On Other Exchanges
Hong Kong
As of 4:01 AM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

northeast tiger pharma co -h (8197) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/20/15 - $0.45
52 Week Low
03/23/15 - $0.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NORTHEAST TIGER PHARMA CO -H (8197)

Related News

No related news articles were found.

northeast tiger pharma co -h (8197) Related Businessweek News

No Related Businessweek News Found

northeast tiger pharma co -h (8197) Details

Northeast Tiger Pharmaceutical Co., Ltd., an investment holding company, develops, manufactures, processes, and sells medicines under the Northeast Tiger brand name in the People’s Republic of China. It is also involved in the breeding, processing, and sale of Chinese medicine herbs, including underground ginseng, asarum, acanthopanax, fritillaria ussuriensis maxim, fragrant solomonseal rhizome, and forest frog. The company was founded in 1998 and is based in Central, Hong Kong.

22 Employees
Last Reported Date: 03/23/15
Founded in 1998

northeast tiger pharma co -h (8197) Top Compensated Officers

General Manager, Compliance Officer and Execu...
Total Annual Compensation: --
Total Annual Compensation: CNY25.0K
Executive Director
Total Annual Compensation: CNY25.0K
Compensation as of Fiscal Year 2013.

northeast tiger pharma co -h (8197) Key Developments

Northeast Tiger Pharmaceutical Co. Ltd. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Northeast Tiger Pharmaceutical Co. Ltd. reported unaudited earnings results for the first quarter ended March 31, 2015. For the first quarter, the company reported operating loss of RMB 951,000 against RMB 1,540,000 a year ago. Loss before taxation was RMB 1,267,000 against RMB 1,899,000 a year ago. Loss after taxation was RMB 1,267,000 against RMB 2,076,000 a year ago. Basic loss per share was 0.20 cents against 0.30 cents a year ago.

Northeast Tiger Pharmaceutical Co. Ltd. to Report Q1, 2015 Results on May 15, 2015

Northeast Tiger Pharmaceutical Co. Ltd. announced that they will report Q1, 2015 results on May 15, 2015

Northeast Tiger Pharmaceutical Co. Ltd., Board Meeting, May 15, 2015

Northeast Tiger Pharmaceutical Co. Ltd., Board Meeting, May 15, 2015., at 16:00 China Standard Time. Agenda: To consider among other matters, approving for publication the announcement of the unaudited first quarterly results of the company for the 3 months ended 31 March 2015; and to consider the payment of an interim dividend (if any).


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8197:HK $0.42 HKD +0.01

8197 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8197.
View Industry Companies

Industry Analysis


Industry Average

Valuation 8197 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7,072.7x
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHEAST TIGER PHARMA CO -H, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at